Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Vascular Pharmacology
- Vol. 116, 36-44
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Canadian Institutes of Health Research (FDN-143299)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 37 references indexed in Scilit:
- Phosphorylation Status of 72 kDa MMP-2 Determines Its Structure and Activity in Response to PeroxynitritePLOS ONE, 2013
- N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart FailurePLOS ONE, 2013
- Inhibition of matrix metalloproteinase‐2 improves endothelial function and prevents hypertension in insulin‐resistant ratsBritish Journal of Pharmacology, 2011
- Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinasesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Titin is a Target of Matrix Metalloproteinase-2Circulation, 2010
- Reactive oxygen species and vascular biology: implications in human hypertensionHypertension Research, 2010
- Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip HypertensionJournal of Cardiac Failure, 2010
- Chemistry and Antihypertensive Effects of Tempol and Other NitroxidesPharmacological Reviews, 2008
- Different Involvement of Extracellular Matrix Components in Small and Large Arteries During Chronic NO Synthase InhibitionHypertension, 2005
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996